Acerus Pharmaceuticals Corporation announced earnings results for the second quarter ended June 30, 2020. For the second quarter, the company announced operating loss was USD 5.050 million compared to USD 2.950 million a year ago. Net loss was USD 5.610 million compared to USD 3.203 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, operating loss was USD 9.305 million compared to USD 6.693 million a year ago. Net loss was USD 10.273 million compared to USD 7.634 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.03 a year ago.